Translating extraordinary science into life-changing therapeutics for patients living with cancer

Accent is taking a novel view of cancer – leveraging our industry-leading expertise in genomic instability and small molecule drug discovery. We look beyond mutation-specific vulnerabilities to identify and exploit critical cellular dependencies resulting from the genomic and chromosomal instability that is observed in multiple types of cancer and develop small molecule therapeutics designed to inhibit those targets and offer far-reaching potential for patients. Our approach has identified numerous high-value programs with the potential to benefit large patient populations with significant unmet medical need.